Vycor Medical Inc VYCO
We take great care to ensure that the data presented and summarized in this overview for VYCOR MEDICAL INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in VYCO
Top Purchases
Top Sells
About VYCO
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Austria and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.
Insider Transactions at VYCO
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
Fountainhead Capital Management LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
535,714
+2.57%
|
$0
$0.11 P/Share
|
|
Jun 30
2022
|
Fountainhead Capital Management LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
535,714
+2.63%
|
$0
$0.14 P/Share
|
|
Mar 31
2022
|
Fountainhead Capital Management LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
535,714
+2.71%
|
$0
$0.08 P/Share
|
|
Sep 30
2021
|
Fountainhead Capital Management LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
1,071,428
+2.82%
|
$0
$0.12 P/Share
|
|
Jun 30
2021
|
Fountainhead Capital Management LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
535,714
+2.94%
|
$0
$0.14 P/Share
|
|
Apr 01
2021
|
Steven Girgenti Director |
BUY
Discretionary transaction
|
Direct |
33
+0.01%
|
$0
$0.21 P/Share
|
|
Mar 31
2021
|
Fountainhead Capital Management LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
535,714
+3.03%
|
$0
$0.21 P/Share
|
|
Mar 31
2021
|
Lowell Rush Director |
BUY
Other acquisition or disposition
|
Direct |
33,333
+5.31%
|
$0
$0.21 P/Share
|
|
Jan 01
2021
|
Steven Girgenti Director |
BUY
Discretionary transaction
|
Direct |
33
+0.01%
|
$0
$0.21 P/Share
|
|
Dec 31
2020
|
Fountainhead Capital Management LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
535,714
+3.13%
|
$0
$0.21 P/Share
|
|
Dec 31
2020
|
Lowell Rush Director |
BUY
Other acquisition or disposition
|
Direct |
33,333
+5.6%
|
$0
$0.21 P/Share
|
|
Oct 01
2020
|
Steven Girgenti Director |
BUY
Discretionary transaction
|
Direct |
33,333
+5.63%
|
$0
$0.21 P/Share
|
|
Sep 30
2020
|
Fountainhead Capital Management LTD > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
535,714
+3.23%
|
$0
$0.21 P/Share
|
|
Sep 30
2020
|
Lowell Rush Director |
BUY
Other acquisition or disposition
|
Direct |
33,333
+5.93%
|
$0
$0.21 P/Share
|